Endo International (ENDP) Debt Trading 1% Lower

Share on StockTwits

An issue of Endo International PLC (NASDAQ:ENDP) (TSE:ENL) bonds fell 1% as a percentage of their face value during trading on Thursday. The debt issue has a 6% coupon and will mature on July 15, 2023. The debt is now trading at $77.75 and was trading at $78.88 last week. Price changes in a company’s bonds in credit markets often anticipate parallel changes in its share price.

ENDP has been the subject of a number of research analyst reports. Svb Leerink lowered shares of Endo International from an “outperform” rating to a “market perform” rating in a research note on Tuesday, March 5th. Zacks Investment Research lowered shares of Endo International from a “hold” rating to a “sell” rating in a research note on Thursday, February 7th. ValuEngine upgraded shares of Endo International from a “sell” rating to a “hold” rating in a research note on Monday, February 4th. Piper Jaffray Companies restated a “hold” rating on shares of Endo International in a research note on Friday, March 1st. Finally, TheStreet lowered shares of Endo International from a “c-” rating to a “d+” rating in a research note on Tuesday, November 27th. Fourteen investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The stock currently has an average rating of “Hold” and an average target price of $15.44.

NASDAQ ENDP traded up $0.03 on Thursday, reaching $8.76. The company’s stock had a trading volume of 3,035,529 shares, compared to its average volume of 3,388,077. Endo International PLC has a twelve month low of $5.27 and a twelve month high of $18.50. The company has a market capitalization of $1.97 billion, a price-to-earnings ratio of 3.03 and a beta of 1.21.

Endo International (NASDAQ:ENDP) (TSE:ENL) last issued its quarterly earnings results on Thursday, February 28th. The company reported $0.75 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.59 by $0.16. Endo International had a negative net margin of 35.00% and a negative return on equity of 337.13%. During the same period in the prior year, the business posted $0.77 earnings per share. On average, sell-side analysts anticipate that Endo International PLC will post 2.17 EPS for the current year.

A number of hedge funds and other institutional investors have recently bought and sold shares of ENDP. Norges Bank acquired a new stake in Endo International during the 4th quarter worth about $21,218,000. Panagora Asset Management Inc. raised its holdings in Endo International by 10,718.5% during the 3rd quarter. Panagora Asset Management Inc. now owns 1,775,205 shares of the company’s stock worth $29,877,000 after buying an additional 1,758,796 shares during the period. Teachers Advisors LLC raised its holdings in Endo International by 230.1% during the 3rd quarter. Teachers Advisors LLC now owns 1,468,025 shares of the company’s stock worth $24,707,000 after buying an additional 1,023,350 shares during the period. Canada Pension Plan Investment Board raised its holdings in Endo International by 143,723.6% during the 4th quarter. Canada Pension Plan Investment Board now owns 730,624 shares of the company’s stock worth $5,333,000 after buying an additional 730,116 shares during the period. Finally, Oregon Public Employees Retirement Fund acquired a new stake in Endo International during the 4th quarter worth about $76,000. Hedge funds and other institutional investors own 92.40% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Endo International (ENDP) Debt Trading 1% Lower” was published by Zolmax and is the property of of Zolmax. If you are accessing this report on another domain, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The correct version of this report can be read at https://zolmax.com/investing/endo-international-endp-debt-trading-1-lower/2980664.html.

About Endo International (NASDAQ:ENDP)

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.

Read More: How do investors use RSI to grade stocks?

Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Short Interest in PepsiCo, Inc.  Grows By 25.7%
Short Interest in PepsiCo, Inc. Grows By 25.7%
Sothebys  Sees Significant Growth in Short Interest
Sothebys Sees Significant Growth in Short Interest
Business First Bancshares Inc  Sees Large Decline in Short Interest
Business First Bancshares Inc Sees Large Decline in Short Interest
Central Garden & Pet Co  Director Brooks Pennington III Sells 1,644 Shares of Stock
Central Garden & Pet Co Director Brooks Pennington III Sells 1,644 Shares of Stock
Analysts Expect Bank of Hawaii Co.  to Announce $1.38 Earnings Per Share
Analysts Expect Bank of Hawaii Co. to Announce $1.38 Earnings Per Share
Soarcoin 1-Day Trading Volume Tops $220.00
Soarcoin 1-Day Trading Volume Tops $220.00


 
© 2006-2019 Zolmax.